Evolent Health, Inc. (CIK: 0001628908) EDGAR, Information, Filings... CompaniesBIO.Com

Evolent Health, Inc.

Mailing address
800 NORTH GLEBE RD, SUITE 500, ARLINGTON, Delaware, 22203
Phone
571-389-6000
State location
Virginia
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8741 - (CF Office: Office of Trade & Services) SERVICES-MANAGEMENT SERVICES
Filings
N/A

Evolent Health, Inc. (CIK: 0001628908) is an American company incorporated in the state of Virginia. Head office is located at 800 NORTH GLEBE RD, SUITE 500, ARLINGTON, Virginia, 22203. Work in the industry 8741 - (CF Office: Office of Trade & Services) SERVICES-MANAGEMENT SERVICES. Evolent Health, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Ajayi Toyin	0001988404	Aug-01-2023	director
Rafferty Emily Ann	0001983577	Jul-03-2023	officer: Chief Operating Officer
Jelinek Richard M	0001707429	Jun-08-2023	director
McCarthy Daniel Joseph	0001946147	Sep-15-2022	officer: PRESIDENT
Sotunde Tunde	0001891237	Oct-28-2021	director
KECK KIM	0001818332	Jan-11-2021	director
Barbarosh Craig A.	0001472457	Dec-21-2020	director
Tutewohl Steve	0001811845	Jun-30-2020	officer: Chief Operating Officer
Shams Aammaad	0001815354	Jun-12-2020	officer: Controller/Prin. Acct. Officer
GRUA PETER J	0001242813	Jan-28-2020	director
Johnson John Paul	0001782040	Jul-01-2019	officer: Chief Financial Officer
UNITEDHEALTH GROUP INC	0000731766	Nov-17-2017	director, other: Director by Deputization
DUFFY MARY BRIDGET	0001570881	Sep-13-2017	director
WILLIAMS FRANK J	0001204938	Sep-14-2016	director, officer: Chief Executive Officer
WIGGINTON STEVE	0001232583	Sep-14-2016	officer: Chief Development Officer
Pomeroy Chad	0001642787	Sep-14-2016	officer: Chief Technology Officer
Thornton Dave	0001642789	Sep-14-2016	officer: Chief Talent Officer
Weinberg Jonathan	0001642833	Sep-14-2016	officer: General Counsel
McGrane Nicholas	0001643086	Sep-14-2016	officer: Chief Financial Officer
Blackley Seth	0001643346	Sep-14-2016	officer: President
Peterson Thomas III	0001643498	Sep-14-2016	officer: Chief Operating Officer
Stone Lydia	0001654824	Aug-15-2016	officer: Principal Accounting Officer
Payson Norman	0000898544	Jul-05-2016	director
SAMET KENNETH A	0001359252	Jul-05-2016	director
Felt Bruce C. Jr.	0001410700	Jul-05-2016	director
Farner David	0001642786	Jul-05-2016	director
Holder Diane	0001642976	Jul-05-2016	director
Scott Cheryl	0001656979	Jul-05-2016	director
D'Amato Michael	0001672282	Apr-12-2016	director
BONDERMAN DAVID	0000860866	Jun-05-2015	10 percent owner
COULTER JAMES G	0001099776	Jun-05-2015	10 percent owner
ADVISORY BOARD CO	0001157377	Jun-05-2015	10 percent owner
HOBART MATTHEW	0001257667	Jun-05-2015	director
Kirshbaum Michael T	0001353721	Jun-05-2015	director
Musslewhite Robert W	0001390194	Jun-05-2015	director
Cann Cynthia Cammett	0001472762	Jun-05-2015	officer: Chief Accounting Officer
TPG Growth II Advisors, Inc.	0001631279	Jun-05-2015	10 percent owner
Piefer Gary	0001643082	Jun-05-2015	officer: Chief Medical Officer
UPMC	0001644244	Jun-05-2015	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Evolent Health, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628908-24-000100 ( Act) Size: 0 KB	Aug-26-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628908-24-000098 ( Act) Size: 0 KB	Aug-26-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628908-24-000096 ( Act) Size: 0 KB	Aug-26-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628908-24-000094 ( Act) Size: 0 KB	Aug-26-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628908-24-000092 ( Act) Size: 0 KB	Aug-26-2024
144/A	Document	Amendment to Filing for proposed sale of securities under Rule 144 Acc-no: 0002002698-24-000277 (33 Act) Size: KB	Aug-23-2024	001-37415 241236152
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0002002698-24-000267 (33 Act) Size: 0 KB	Aug-22-2024	001-37415 241231981
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0002002698-24-000266 (33 Act) Size: 0 KB	Aug-22-2024	001-37415 241231947
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0002002698-24-000265 (33 Act) Size: 0 KB	Aug-22-2024	001-37415 241231935
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0002002698-24-000264 (33 Act) Size: 0 KB	Aug-22-2024	001-37415 241231915
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001628908-24-000090 (34 Act) Size: KB	Aug-09-2024	001-37415 241189867
8-K	Document	Current report filing Acc-no: 0001628908-24-000089 (34 Act) Size: KB	Aug-08-2024	001-37415 241188614
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902219-24-000314 (34 Act) Size: KB	Aug-07-2024	005-89390 241181476
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628908-24-000082 ( Act) Size: 0 KB	Aug-05-2024
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-24-001840 (34 Act) Size: KB	Jul-10-2024	005-89390 241108971
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-072466 (34 Act) Size: KB	Jun-17-2024	005-89390 241049934
8-K	Document	Current report filing Acc-no: 0001628908-24-000080 (34 Act) Size: KB	Jun-11-2024	001-37415 241035823
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628908-24-000077 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628908-24-000076 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628908-24-000075 ( Act) Size: 0 KB	Jun-10-2024

Recent 20 filings. View all Evolent Health, Inc. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Evolent Health, Inc. overview
Evolent Health, Inc. job
Evolent Health, Inc. stock
Evolent Health, Inc. ownership
Evolent Health, Inc. CEO
Evolent Health, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.